BLPH - Bellerophon Therapeutics Inc
Previous close
0.035
0 0%
Share volume: 104,923
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.04
0.00
0.00%
Summary score
23%
Profitability
25%
Dept financing
15%
Liquidity
50%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-58.63%
Return on assets
-23.29%
Return on sales
0%
Return on invested capital
64.85%
Total debt ratio
71.2%
Debt ratio change over timeo
-0.46%
Current Ratio
3.63%
Quick Ratio
0%
Cash Position Ratio
2.87%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-102.67%
Return on assets
-26.31%
Return on sales
0%
Return on invested capital
99.45%
Total debt ratio
56.15%
Debt ratio change over timeo
-0.42%
Current Ratio
3.46%
Quick Ratio
0%
Cash Position Ratio
3.37%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.15%
Return on assets
-9.19%
Return on sales
0%
Return on invested capital
90.14%
Total debt ratio
14.77%
Debt ratio change over time
-0.87%
Current Ratio
9.17%
Quick Ratio
0%
Cash Position Ratio
9.03%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-167.94%
Return on assets
-120.89%
Return on sales
0%
Return on invested capital
0.57%
Total debt ratio
-46.11%
Debt ratio change over time
-0.46%
Current Ratio
2.32%
Quick Ratio
0%
Cash Position Ratio
2.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BLPH | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -58.63% | -3.05% | 11.55% | 6.27% |
| Return on assets | -23.29% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 64.85% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 38% | 70% | 63% |
| Total debt ratio | 71.2% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.46% | 6.09% | 6.03% | 1.53% |
| Dept financing | 18% | 50% | 43% | 14% |
| Current Ratio | 3.46% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.37% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 27% | 55% | 59% |
| Short-term ratios | BLPH | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -102.67% | -25.62% | 17.94% | 7.14% |
| Return on assets | -26.31% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 99.45% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 40% | 71% | 62% |
| Total debt ratio | 56.15% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.42% | -23.44% | 9.66% | 0.6% |
| Dept financing | 13% | 25% | 45% | 8% |
| Current Ratio | 3.46% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.37% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 43% | 35% | 61% |